Quantification of disease activity in patients undergoing leucocyte scintigraphy for suspected inflammatory bowel disease

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 32, Issue 3, 2005, Pages 329-337

  Cheow, Heok K ^a   Voutnis, Demetrius D ^a   Evans, John W ^a   Szczepura, Katy R ^a   Swift, E Anna ^a   Bird, Nicholas J ^a   Ruparelia, Prina ^a   Solanki, Chandra K ^a   Ballinger, James R ^a   Chilvers, Edwin R ^a   Middleton, Stephen J ^a   Peters, A Michael ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

111In granulocytes; 99mTc HMPAO labelled leucocytes; Inflammatory bowel disease; Whole body counting

Indexed keywords

INDIUM 111; TECHNETIUM 99M;

ADULT; AGED; ARTICLE; CELL FRACTIONATION; CELL LABELING; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DIAGNOSTIC IMAGING; DISEASE ACTIVITY; ENTERITIS; FEMALE; GAMMA SCINTIGRAPHY; HUMAN; HUMAN CELL; LEUKOCYTE; MALE; QUANTITATIVE ANALYSIS; WHOLE BODY COUNTER; WHOLE BODY COUNTING;

ADULT; AGED; FEASIBILITY STUDIES; FEMALE; GRANULOCYTES; HUMANS; INDIUM RADIOISOTOPES; INFLAMMATORY BOWEL DISEASES; LEUKOCYTES; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TECHNETIUM TC 99M EXAMETAZIME; WHOLE-BODY COUNTING;

EID: 20244370220     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-004-1617-7     Document Type: Article

References (18)

1. Saverymuttu SH, Peters AM, Hodgson HJ, Chadwick VS, Lavender JP. Indium-111 autologous leucocyte scanning: comparison with radiology for imaging the colon in inflammatory bowel disease. Br Med J 1982;285:255-7.
2. Scholmerich J, Schmidt E, Schumichen C, Billmann P, Schmidt H, Gerok W. Scintigraphic assessment of bowel involvement and disease activity in Crohn's disease using technetium 99m-hexamethyl propylene amine oxine as leukocyte label. Gastroenterology 1988;95:1287-93.
3. Arndt JW, van der Sluys Veer A, Blok D, Griffoen G, Verspaget HW, Lamers CB, Pauwels EK. Prospective comparative study of technetium-99m-WBCs and indium-111-granulocytes for the examination of patients with inflammatory bowel disease. J Nucl Med 1993;34:1052-7.
4. Peters AM, Danpure HJ, Osman S, Hawker RJ, Henderson BE, Hodgson HJ, et al. Preliminary clinical experience with Tc-99m-HMPAO for labelling leucocytes and imaging inflammation. Lancet 1986;2:946-9.
5. Mansfield JC, Giaffer MH, Tindale WB, Holdsworth CD. Quantitative assessment of overall inflammatory bowel disease activity using labelled leucocytes: a direct comparison between indium-111 and technetium-99m HMPAO methods. Gut 1995;37:679-83.
6. Saverymuttu SH, Peters AM, Hodgson HJ, Chadwick VS, Lavender JP. Quantitative faecal 111-indium leucocyte excretion in the assessment of disease activity in Crohn's disease. Gastroenterology 1983;85:1333-9.
7. Saverymuttu SH, Peters AM, Keshavarzian A, Reavy HJ, Lavender JP. The kinetics of 111-indium distribution following injection of 111-indium labelled autologous granulocytes in man. Br J Haematol 1985;61:675-85.
8. Saverymuttu SH, Peters AM, Hodgson HJ, Chadwick VS. Assessment of disease activity in ulcerative colitis using 111-indium labelled leucocyte faecal excretion. Scand J Gastroenterol 1983;18:907-12.
9. 111In-labeled granulocytes. Digestion 1991;50:149-52.
10. Currie DC, Saverymuttu SH, Peters AM, Needham SG, George P, Dhillon DP, et al. Indium-111 labelled granulocyte accumulation in respiratory tract of patients with bronchiectasis. Lancet 1987;1:1335-9.
11. Currie DC, Peters AM, Garbett ND, George P, Strickland B, Lavender JP, Cole PJ. In-111 labelled granulocyte scanning to detect inflammation in the lungs of patients with chronic sputum expectation. Thorax 1990;45:541-4.
12. Carpani de Kaski M, Peters AM, Knight D, Stuttle AWJ, Lavender JP, Hodgson HJ. In-111 whole body retention: a new method for quantification of disease activity in inflammatory bowel disease. J Nucl Med 1992;33:756-62.
13. Hayball MP, Dendy PP. Baseline levels of total-body radioactivity determined by whole body monitoring. Radiat Prot Dosimetry 1991;36:93-6.
14. 111indium tropolonate-labeled leucocytes. J Nucl Med 1983;24:39-44.
15. Carpani de Kaski M, Peters AM, Lavender JP, Hodgson HJF. Fluticasone propionate in Crohn's disease. Gut 1991;32:657-61.
16. Chisholm PM, Danpure HJ, Healey G, Osman S. Cell damage resulting from the labeling of rat lymphocytes and HeLa S3 cells with In-111 oxine. J Nucl Med 1979;20:1308-11.
17. Dancey JT, Deubelbeiss KA, Harker LA, Finch CA. Neutrophil kinetics in man. J Clin Invest 1976;58:705-15.
18. Peters AM, Roddie ML, Danpure HJ, Osman S, Zacharopoulos GP, George P, et al. Tc-99m HMPAO labelled leucocytes: comparison with In-111-tropolonate labelled granulocytes. Nucl Med Commun 1988;9:449-63.